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PRELIMINARY STUDY OF THE GENETICS OF RESISTANCE IN THE HOUSE MOUSE
COLIN V. PRESCOTT, School of Animal and Microbial Sciences, University of Reading, Whiteknights, Reading,
Berkshire RG6 2AJ, United Kingdom.
ABSTRACT: A wild house mouse (Mus domesticus) population originally trapped near Reading, Berkshire, United
Kingdom, and maintained as a colony in the laboratory, was subjected to the discriminating feeding period of the
warfarin resistance test, as used by Wallace and MacSwiney (1976) and derived from the work of Rowe and Redfern
(1964). Eighty percent of this heterogeneous population survived the resistance test. A similar proportion of the
population was found to survive the normally lethal dose of bromadiolone administered by oral gavage. The majority
of this population of mice were classified as "warfarin-resistant" and "bromadiolone-resistant." The dose of lOmg.kg1
of bromadiolone administered by oral gavage appeared to give good discrimination between susceptible and resistant
individuals. The results of breeding tests indicate a single dominant gene that confers both "warfarin-resistance" and
"bromadiolone-resistance," with complete expression of the resistance genotype in both males and females. Individual
mice were classified as to genotype by back-crossing to a homozygous-susceptible strain, and resistance-testing the F1
generation. Separate strains of homozygous-resistant and homozygous-susceptible house mice are now being established.
KEY WORDS: rodenticide resistance, warfarin, bromadiolone, house mouse
Proc. 17th Vertebr. Pest Conf. (R.M. Timm & A.C. Crabb,
Eds.) Published at Univ. of Calif., Davis. 1996.
INTRODUCTION
House mice (Mus domesticus) (Marshall and Sage
1981) have a naturally low susceptibility to first
generation anticoagulants. For example, the acute oral
LD50 is reported for warfarin to be 374 mg.kg 1 (Hagan
and Radomski 1953) and for diphacinone to be 250 to 300
mg.kg 1 (Itoh et al. 1973).
Warfarin resistance in the house mouse was first
described by Dodsworth (1961), although at that time it
was not considered to be widespread. Rowe and Redfern
(1964) acknowledged that some house mouse populations
were extremely difficult to kill with warfarin and,
therefore, investigated its toxicity to mice in the
laboratory. The test animals were obtained from breeding
pens which were stocked from 13 different localities
where no previous warfarin treatment had been carried
out. In the test, individually caged mice were offered an
unrestricted amount of 250 ppm warfarin for a fixed
number of days, weighing food consumption, and
recording survival or mortality. Thirteen mice were
tested over a 28-day feeding period resulting in complete
mortality. However, of 53 mice tested over a 21-day
feeding period, five animals survived. Rowe and Redfern
(1965) suggested that these survivors are indicative of the
probable presence of mice "resistant" to 250 ppm
warfarin in any sizable mouse population.
Apart from the work of Rowe and Redfern (1964),
which was concerned specifically with the toxicity of
warfarin to house mice, there is no published laboratory
test to identify anticoagulant-resistance in the house
mouse. On the basis of the results of Rowe and Redfern
(1964), Wallace and MacSwiney (1976) used a 21-day
feeding period on a 250 ppm bait as a warfarin-resistance
test to discriminate between warfarin-resistant and
warfarin-susceptible individuals. In this way, they were
able to demonstrate that warfarin resistance in the house
mouse was controlled by a major resistance gene, which
they designated "War;" whose expression was very
variable and strongly influenced by modifiers (MacSwiney

and Wallace 1978).
This paper deals with a stock of wild house mice
(Mus domesticus) trapped near Reading, Berkshire,
United Kingdom (UK). The mice were initially shown to
be resistant to warfarin by the 21-day warfarin feeding
test (Rowe and Redfern 1964). Subsequently, it was
found that the warfarin resistant stock were relatively
resistant to bromadiolone, and a dose of bromadiolone
was established that would distinguish between the
susceptible and resistant phenotypes. This was then used
to demonstrate single factor inheritance of the resistance.
METHODS
Wild anticoagulant-resistant stock were derived from
mice trapped from a warfarin-resistant infestation near
Reading (Berkshire, UK), and subsequently maintained in
population pens. The anticoagulant-susceptible stock
were albino Swiss mice (CD-I) obtained from Charles
River UK Ltd.
Except where stated, all animals were maintained on
laboratory diet (PCD MOD [C] FG; Special Diet
Services; Wiltham, Essex, UK). This diet contains a
supplement of vitamin K3 at 10 ppm.
Warfarin was obtained as a proprietary 250 ppm bait
formulation. Bromadiolone was obtained as a proprietary
0.1% liquid concentrate and as a 0.23% liquid
concentrate.
The concentrations of warfarin and
bromadiolone were verified by HPLC.
Lethal Feeding-Period Test
Five male and five female wild mice were weighed,
individually caged in stainless steel test cages with mesh
floors, and maintained on ground laboratory diet in food
bowls which were held in place by metal clips. Food
consumption was measured daily for each mouse, taking
spillage into account.
The test animals were then
presented with the 250 ppm warfarin diet for a no-choice
feeding period of 21 days. Again food consumption was
measured daily for each mouse, taking spillage into
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account. The animals were then maintained on the ground
laboratory diet for an observation period of 28 days.
Throughout the experiment, the test animals were
inspected for signs of toxicosis. At death, or at the end
of the observation period, the animals were weighed
again.

Table 2.
Wild house mice—mortality following
intubation with bromadiolone over a range of doses.

Intubation
Groups of animals were either received from Charles
River UK Ltd., or removed from the population pen, and
maintained in single sexed groups for an acclimatization
period. They were then weighed, and dosed by gavage
with the required concentration of bromadiolone at a rate
of 1 ml per 100 g body weight; to achieve the highest
dosage of 34.5 mg. kg', the 0.23% concentrate was dosed
at a rate of 1.5 ml per 100 g body weight. Animals were
not starved prior to dosing. They were then maintained
in single sex groups for an observation period of 21 days.
Throughout the experiment, the test animals were
inspected for signs of toxicosis.

Dose of warfarin consumed (mg.kg"1)
Survived
Died
Mortality
mean (range)
mean (range)
0/5
2/5

808 (657-1084)
973 (842-1077)

Mortality

2.9
2.9
5.8
5.8
11.5
11.5
34.5
34.5

male
female
male
female
male
female
male
female

1/3
0/3
1/3
1/3
0/3
0/3
0/6
0/6

Dosed
(mg.kg-1)

Sex

Mortality

0.9
0.9
1.8
1.8
3.6
3.6
7.2
7.2

male
female
male
female
male
female
male
female

0/10
0/10
7/10
7/10
10/10
10/10
10/10
10/10

Breeding Experiments
The inheritance of the bromadiolone resistance was
examined by setting up a series of breeding experiments
in which the putative resistance gene is represented by R,
and its allele for susceptibility is represented by r. The
principal type of design employed was the Test-Cross, in
which the wild mouse of unknown genotype (RR, Rr or
rr) is crossed with a mouse of the anticoagulantsusceptible Swiss strain, which is of known genotype rr.
In a Test-Cross, assuming unifactorial dominant
inheritance, the expected proportions of resistant offspring
of homozygous resistant (RR), heterozygous (Rr) and
homozygous susceptible (rr) parents are 100%, 50%, and
0%, respectively. If the Test-Cross offspring were given
a dose of bromadiolone that would selectively kill
susceptible animals, then assuming a dominant gene,
mortality for offspring of homozygous resistant (RR),
heterozygous (Rr) and homozygous susceptible (rr) parent
would be 0%, 50%, and 100%, respectively.
As a discriminating "Gavage Test" bromadiolone was
administered at 10 mg.kg'1 body weight, a dose between
5.7 and 10.1 times greater than published LD50 values,
and which would be lethal to susceptible Swiss mice
(Table 3), but that was much less than the maximum
dose survived by the putative "resistant" Campus Main
Water Distribution System Upgrade - Phase I house mice
(Table 2).

Table 1. Wild house mice—mortality and warfarin dose
consumed during 21-day no-choice feed on warfarin bait.

Male
Female

Sex

Table 3. Anticoagulant-susceptible Swiss mice—mortality
following intubation with bromadiolone.

RESULTS
Feeding Test With Warfarin
The results of the 21-day warfarin feeding test are
presented in Table 1. Only two out of the ten animals
died. They had consumed less than 30% of the warfarin
formulation consumed by the survivors. The eight
survivors showed no reduction in daily food consumption
during the test, demonstrating a high level of resistance to
warfarin. The contrast in the amount of active ingredient
consumed by the survivors and those that died, suggests
two distinct levels of susceptibility to the anticoagulant.
The results indicate that 80% of the house mouse stock
were warfarin-resistant and 20% were warfarinsusceptible.

Sex

Dosed
(mg. kg"1)

195 (149-241)

Bromadiolone Toxicity By Gavage
The results of the initial bromadiolone gavage tests
with the "Reading" house mice are presented in Table 2.
Of the 30 mice that received a potentially lethal dose of
bromadiolone, three animals died (10%). The proportion
of animals that survived bromadiolone was comparable
with the 80% of animals that survived the 21-day warfarin
feeding test, suggesting a high level of cross-resistance
between the two anticoagulants.
The results of the bromadiolone gavage tests with the
anticoagulant-susceptible Swiss mice are presented in
Table 3. A bromadiolone dose of 1.8 mg.kg 1 body
weight achieved incomplete mortality in both males and
females. A dose of 0.9 mg.kg"1 gave no mortality, and a
dose of 3.6 mg.kg"1 and above, gave complete mortality.

84

The results of Test-Crosses for 29 untreated wild mice
are shown in Table 4. Significantly more females (10/14)
than males (5/15) were homozygous resistant (x2 = 5.32;
d.f. = 1; p = 0.02), suggesting a sex-related effect on
the fitness of the resistance genotype.
Mortality using the male Test-Cross offspring was
19.8% (39/197), slightly but not significantly greater than
the 18.4% using the female Test-Cross offspring; 29/158
(0 x 2 = 0.049; d.f. = 1; p = 0.8-0.9).
Mortality among the offspring of putative
heterozygotes was 44% (68/153), slightly less than the
theoretical 50% (x2 = 1.67; d.f. = 1; p = 0.1 to 0.05).
Litter size was substantially greater where the female
parent was a Swiss mouse (mean litter size of 15.7;
compared with 8.6 for wild females), presumably owing
to the superior mothering ability of the domesticated
strain.
If we define resistance as 100% survival, and
susceptibility as 100% mortality in the Gavage Test, then
the results are consistent with the hypothesis that the
bromadiolone resistance is due to a single dominant
autosomal gene. On this basis, assuming no selection
within the population pen, the frequency of the resistance
gene can be calculated to be 0.74, and the theoretical
frequencies of the RR, Rr, and rr genotypes as 0.55,
0.38, and 0.07, respectively.

Although the risk that the test misidentified a few
animals cannot be excluded at this stage, the results of the
breeding study strongly indicate a genetic basis for
bromadiolone resistance in the wild "Reading" mice,
which is consistent with a single dominant autosomal gene
controlling the resistance phenotype.
There are numerous reports in the literature of house
mice suspected to be resistance to the second generation
anticoagulant bromadiolone, based on their survival of a
21-day feeding test on the field strength (50 ppm)
formulation.
Rowe et al. (1981) investigated the efficacy of 50 ppm
bromadiolone against groups of house mice in a pen
environment with alternative food available, and in six
field treatments. Survivors from both the pen and the
field were subjected to either a 50 ppm or a 100 ppm
bromadiolone formulation for a no-choice feeding period
of 21 days. Ten individuals survived after consuming
between 118 and 410 mg.kg 1 body weight of
bromadiolone.
MacNicoll and Gill (1987) considered 11 out of 30
wild house mice were resistant to bromadiolone following
their survival of a 21-day feeding test on a 50 ppm
bromadiolone formulation.
Lund (1984) investigated the effect of bromadiolone
against the Mus musculus species of house mice trapped
from Denmark and southern Sweden, using no-choice
feeding tests of up to ten days duration, and formulation
strengths of 50 ppm and 100 ppm. He reported mice
surviving following consumption of up to 115.8 mg.kg"1
body weight of bromadiolone, and considered that this
was resistance of practical importance.
Unlike the major gene controlling warfarin-resistance
in the house mouse (Wallace and MacSwiney 1976), the
putative gene controlling bromadiolone resistance in the
"Reading" mice would appear to be fully expressed in
both males and females. This may be an artifact of the
test doses chosen, since in resistance studies the
expression of a gene always varies with the dose
administered.
Rowe and Redfern (1967) in a study with LAC Grey
mice, noted that male mice were more susceptible to
warfarin than female mice. The incomplete dominance of
the warfarin resistance gene, as reported by Wallace and
MacSwiney (1976) may indicate that the 21-day feeding
test on a 250 ppm warfarin bait was too severe to
effectively separate resistant from susceptible male
individuals. Although this discriminating feeding period
distinguished resistant and susceptible female mice
effectively, a number of male warfarin-resistant mice
must have died as a result of the feeding test, and have
been misclassified. The original toxicity data of Rowe
and Redfern (1964) made no attempt to establish a
resistance baseline, and gave no mention of the increased
susceptibility of male mice, which they were to report in
their later publication.
Although practical bromadiolone resistance occurs in
field populations of house mice, the authors have as yet
no evidence that the levels detected in the "Reading"
stock are of significance. This will require further
investigation.

Development of Wild Homozygous Strains
The breeding nucleus of a putatively homozygous
resistant strain of pure wild ancestry was formed from the
eight mice (two males and six females) indicated by
asterisk in Table 3. To date all 40 of their offspring have
received and survived a Gavage Test.
The female mouse 94/16 (Table 3) was shown by the
Test-Cross to be of the susceptible (rr) genotype. It was
crossed with a wild heterozygote and the offspring were
Test-Crossed.
By this means, two homozygous
susceptible (rr) offspring were identified, and were mated
together to form the breeding nucleus of a bromadiolonesusceptible strain of pure wild ancestry. The Gavage Test
has given complete mortality in all eight of their offspring
tested to date.
DISCUSSION
Published LD50 values for bromadiolone are 0.99
mg.kg 1 (Meehan 1978) and 1.75 mg.kg "' (Grand 1976).
Other published bromadiolone toxicity data against the
house mouse refer to no-choice feeding tests, where the
animals are fed bromadiolone bait, normally containing
50 ppm of active ingredient for a pre-determined period
of whole days. Since a mouse would normally consume
between 10 to 20 mg.kg 1 body weight of active ingredient
per day, feeding on a 50 ppm formulation in a no-choice
situation, this type of toxicity data is of little value in
determining the toxicity of bromadiolone to a susceptible
house mouse.
The bromadiolone toxicity data presented for
anticoagulant-susceptible Swiss mice in Table 3
correspond well with the published acute oral LD50 value
of 1.75 mg.kg"1 (Grand 1976), and provide support for the
Gavage Test, that dosing at 10 mg.kg"1 is lethal to
anticoagulant-susceptible mice.
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Table 4. Genotype determination of wild house mice, by performing a Test Cross with an anticoagulantsusceptible mouse, and testing the litter with a Gavage Test (dosing bromadiolone at 10 mg.kg 1 body
weight).

Test Cross Litter
Males
Females

Mortality following Intubation of
Bromadiolone at 10 mg.kg 1
Females
Males

Animal
No.

Sex

93/1*

male

4

7

0/4

0/7

RR

93/2*

male

5

9

3/5

3/9

Rr

93/3*

female

6

4

0/6

0/4

RR

93/5*

female

3

7

0/3

0/7

RR

93/6*

female

11

0

0/11

0/0

RR

93/7*

female

7

2

0/7

0/2

RR

93/8*

female

1

9

0/1

0/9

RR

93/9*

female

1

7

0/1

0/7

RR

93/10

male

6

8

4/6

6/8

Rr

93/11*

male

6

6

0/6

0/6

RR

93/12

male

11

8

9/11

3/8

Rr

93/13

male

6

8

1/6

1/8

Rr

93/14

male

6

5

2/6

2/5

Rr

94/1

male

8

6

4/8

1/6

Rr

94/2

male

8

5

6/8

3/5

Rr

94/3

female

4

4

2/4

1/4

Rr

94/4

male

7

5

5/7

1/5

Rr

94/5

male

7

7

2/7

2/7

Rr

94/6

male

3

4

1/3

0/4

Rr

94/7

male

7

5

0/7

0/5

RR

94/8

male

5

10

0/5

0/10

RR

94/12

female

5

2

2/5

0/2

Rr

94/13

female

5

3

0/5

0/3

RR

94/15

female

4

3

0/4

0/3

RR

94/16

female

4

5

4/4

5/5

rr

94/17

male

6

8

0/6

0/8

RR

94/18

female

5

3

0/5

0/3

RR

94/20

female

4

5

0/4

0/5

RR

94/21

female

3

3

3/3

1/3

Rr

RR = homozygous resistant
Rr = heterozygous resistant
rr = homozygous susceptible
*This was referred to earlier in text.
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Suspected Resistance
Status of Wild Parent
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